Fibroepithelial Breast Lesion: When Sequencing Can Help to Make a Clinical Decision. A Case Report
Clin Breast Cancer
.
2019 Feb;19(1):e1-e6.
doi: 10.1016/j.clbc.2018.10.007.
Epub 2018 Nov 1.
Authors
Giacomo Montagna
1
,
Charlotte K Y Ng
2
,
Tatjana Vlajnic
3
,
Viola Paradiso
3
,
Sophie Dellas
4
,
Hubertina Reina
5
,
André Kind
5
,
Walter P Weber
5
,
Salvatore Piscuoglio
3
,
Christian Kurzeder
5
Affiliations
1
Breast Center, University Hospital Basel, Basel, Switzerland. Electronic address:
[email protected]
.
2
Department of Biomedicine, University of Basel, Basel, Switzerland; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
3
Institute of Pathology, University Hospital Basel, Basel, Switzerland.
4
Department of Radiology, University Hospital Basel, Basel, Switzerland.
5
Breast Center, University Hospital Basel, Basel, Switzerland.
PMID:
30470624
DOI:
10.1016/j.clbc.2018.10.007
No abstract available
Keywords:
Diagnostic accuracy; Fibroepithelial breast lesion; MED12; Phyllodes tumor; TERT promoter.
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Breast Neoplasms*
Female
Humans